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Abstract
Chemical modification in combination with site-directed mutagenesis was used to identify a tyrosine residue responsible
for the increase in ecto-nucleoside triphosphate diphosphohydrolase 3 (NTPDase3) nucleotidase activity after acetylation
with a tyrosine-selective reagent, N-acetylimidazole. The NTPDase3 ATPase activity is increased more than the ADPase
activity by this reagent. Several fairly well conserved tyrosine residues (252, 255, and 262) that are located in or very near
apyrase conserved region 4a (ACR4a) were mutated. These mutants were all active, but mutation of tyrosine 252 to either
alanine or phenylalanine eliminated the activity increase observed after N-acetylimidazole treatment of the wild-type
enzyme. This suggests that the acetylation of tyrosine 252 is responsible for the increased activity. Stabilization of
quaternary structure has resulted in increased enzyme activities for the NTPDases. However, mutation of these three
tyrosine residues did not result in global changes of tertiary or quaternary structure, as measured by Cibacron blue
binding, chemical cross linking, and native gel electrophoretic analysis. Nevertheless, disruption of the oligomeric
structure with the detergent Triton X-100 abolished the increase in activity induced by this reagent. In addition, mutations
that abolished the N-acetylimidazole effect also attenuated the increases of enzyme activity observed after lectin and
chemical cross-linking treatments, which were previously attributed to stabilization of the quaternary structure. Thus, we
speculate that the acetylation of tyrosine 252 might induce a subtle conformational change in NTPDase3, resulting in the
observed increase in activity.
Abbreviations: ACR –apyrase conserved region; BSA–bovine serum albumin; Con A–Concanavalin A; DMEM–
(Dulbecco’s modified Eagle medium); DMSO–dimethyl sulfoxide; DSS–disuccinimido suberate; DTT–(dithiothreitol);
MOPS– (3-[N-morpholino] propanesulfonic acid; N-AI– N-acetylimidazole; NTPDases– (nucleoside triphosphate
diphosphohydrolases); Pi–(inorganic phosphate); PVDF–polyvinylidene fluoride; TBS–(tris buffered saline)
Introduction
The eNTPDases are a family of enzymes that hydrolyze
extracellular nucleoside 5¶ di- and triphosphates in the
presence of divalent cations [1]. There are integral
membrane protein NTPDases, embedded in both the cell
surface membrane and internal membranes, as well as
NTPDases that can be secreted extracellularly as soluble
nucleotidases [2Y7]. Four of the eight human NTPDases
described to date (NTPDase1Y3, 8) are integral membrane,
cell-surface glycoproteins, with large extracellular domains
and two transmembrane domains located near the N- and
C-termini [1, 8].
Several areas of sequence conservation in the NTPDases
have been noted. Besides the four apyrase conserved
regions (ACRs) originally described [9], and ACR5
described later [10, 11], there are also two other conserved
protein motifs in the NTPDases that have been named
ACR1a and ACR4a [12]. No amino acid residues in the
ACR1a region have thus far been assigned any functional
significance. However, ACR4a was found to include a
conserved glycine residue (glycine 263 in NTPDase3 [12])
whose mutation to alanine caused complete inactivation of
the enzyme, presumably by large-scale disruption of native
tertiary and quaternary structures of the nucleotidase [12].
A similar, but slightly less pronounced effect was found by
mutation of another conserved glycine residue to alanine in
NTPDase3, i.e., glycine 462, located in ACR5 [12].
The enzymatic activities, and therefore presumably the
physiological functions, of the cell-surface NTPDases are
dependent on their oligomeric state (quaternary structure).
Correspondence to: Dr Terence L. Kirley, Department of Pharmacology
and Cell Biophysics, University of Cincinnati College of Medicine, 231
Albert Sabin Way, Cincinnati, OH 45267-0575, USA. Tel: +1-513-558-
2338; Fax: +1-513-558-1169; E-mail: terry.kirley@uc.edu
Purinergic Signalling (2005) 1: 271–280 # Springer 2005
DOI: 10.1007/s11302-005-0650-8Conditions that stabilize NTPDase homo-oligomers in-
crease activity, while conditions that destabilize NTPDase
oligomers decrease nucleotidase activities [13]. For exam-
ple, solubilization with Triton X-100 detergent disrupts the
native oligomeric structure and dramatically decreases
nucleotidase activities for both NTPDase1 (CD39 [14])
and NTPDase3 [15]. Lectins such as the tetravalent Con A
protein can induce lattices of specific glycoproteins, even
in the presence of complex mixtures of glycoproteins
exposed to Con A [16]. Thus, several studies have reported
that Con A increases NTPDase activity [17Y19], presum-
ably by stabilization of the quaternary structure. At least in
NTPDase3, this Con A effect seems to be mediated via the
conserved N81 glycosylation site, located near ACR1 [20].
It has also been shown that chemical cross-linking can
stabilize quaternary structure, and therefore the lysine
specific cross-linking agent, DSS, has been used to assess
possible changes in quaternary structure as a consequence
of site-directed mutagenesis of NTPDase3 [12, 21Y24]. Of
course, the enzymatic activities of the NTPDases are also
dependent on their tertiary structures. Cibacron blue
(Reactive Blue 2) is a triazine dye that has affinity for
the nucleotide binding site of many proteins, and has been
shown to inhibit nucleotide handling enzymes in general
[25, 26], as well as specific NTPDases [27, 28]. Cibacron
blue binding to NTPDase3 is retained after solubilization
and monomerization with Triton X-100 [12]. As a con-
sequence, this dye has been used as a measure of native
tertiary structure for NTPDase3, since it does not bind to
heat-denatured NTPDase3 or to certain mutants that appear
to have disrupted tertiary structures [29].
While screening chemical modification reagents for
effects on NTPDase3 nucleotidase activities, we made the
unusual and unexpected observation that reaction of wild-
type NTPDase3 with the tyrosine selective reagent, N-
acetylimidazole, increases enzyme activity. Previously,
treatment with aspirin (acetylsalicylic acid) was shown to
inhibit rat platelet NTPDase [30], possibly via acetylation.
In the present study, it seems unlikely that an increase in
NTPDase3 activity would be induced by acetylation of an
active site residue by N-acetylimidazole. Therefore, we
mutated several conserved tyrosine residues in the vicinity
of the glycine residue that was previously proposed to be
important for NTPDase3 higher-order structure (glycine
263 in ACR4a [12]). These tyrosine residues are also
located near the computer-predicted helixYloopYhelix
dimerization domain in the primary structure of NTPDase3
(
238NTSDIMQVS
246 [31]).
We found that substitution of tyrosine at position 252
abolished the increase in activity caused by N-acetylimi-
dazole, suggesting that modification of this tyrosine
residue is responsible for the increased activity of the
wild-type enzyme. Monomerization of the wild-type
enzyme by solubilization with the detergent Triton X-100
eliminated the increase in activity upon treatment with N-
acetylimidazole. However, no gross changes in the tertiary
or quaternary structures were detected by Cibacron blue
binding, DSS cross-linking, or native gel electrophoresis.
Nevertheless, changes in response to lectin and cross-
linking induced increases in nucleotidase activities were
evident in the mutants non-responsive to N-acetylimida-
zole. Therefore, we speculate that Tyr 252, as well as the
amino acid residues nearby Tyr 252 in ACR4a, may be
important for full enzymatic activity of NTPDase3 due to
their subtle influence on native tertiary and/or quaternary
structure.
Materials and methods
Materials
The QuikChangei site-directed mutagenesis kit was pur-
chased from Stratagene. Oligonucleotides were synthesized
by the DNA Core Facility at the University of Cincinnati.
Lipofectamine Plus Reagent, Dulbecco’s modified Eagle
medium (DMEM), calf serum, and antibiotics/antimycotics
were obtained from Gibco/Life Technologies. The mamma-
lian expression vector pcDNA3 was obtained from Invitro-
gen. The chemical cross-linking reagent disuccinimidyl
suberate (DSS) and the SuperSignal chemiluminescence re-
agents were purchased from Pierce Chemical Company.
Cibacron Blue Gel (Affi-Gel Blue), pre-cast SDS-PAGE
4%Y15% gradient mini-gels, and goat anti-rabbit horserad-
ish peroxidase conjugated secondary antibody were obtained
from Bio-Rad Laboratories. N-Acetylimidazole (N-AI), Am-
picillin, nucleotides, and other reagents were from Sigma.
Site-directed mutagenesis of NTPDase3
Mutagenesis of NTPDase3 in pcDNA3 vector was per-
formed using the Quick Change site-directed mutagenesis
kit (Stratagene) as described previously [12, 15, 23, 24, 29,
32]. The sense nucleotides used for mutagenesis are as
follows:
Y252A, 5¶-CTGTATGGCTACGTAGCAACGCTCTACA-
CACAC-3¶;
Y255A, 5¶-TACGTATACACGCTCGCAACACA-
CAGCTTCCAG-3¶;
Y262A, 5¶-CACAGCTTCCAGTGCGCAGGCCGGAAT-
GAGGCT-¶3;
Y252F, 5¶-TATGGCTACGTATTCACGCTCTACACA-3¶;
Y255F, 5¶-GTATACACGCTCTTCACACACAGCTTC-3¶;
Y262F, 5¶-AGCTTCCAGTGCTTTGGCCGGAATGAG-¶3;
Altered codons are underlined, but the complementary
antisense oligonucleotides also necessary for mutagenesis
are not shown. The presence of the desired mutation and
lack of undesired mutations were confirmed by DNA
sequencing. The mutated NTPDase3 cDNA was used to
transform competent cells as described by the manufacturer
(Stratagene).
Transient transfection
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and mutant NTPDase3 cDNA, as previously described
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t r a n s f e c t e di n t oC O Sc e l l s and used as a background
control for nucleotidase assays. Cells were harvested 48
h post-transfection and crude total membrane preparations
were obtained as described [12, 15, 23, 24, 29, 32].
Protein assay
Protein concentrations were determined using the Bio-
Rad Coomassie blue dye binding assay, using bovine
serum albumin as the standard, with the modifications of
Stoscheck [33].
Nucleotidase assays
Nucleotidase activities were determined by measuring the
concentration of inorganic phosphate (Pi) released from the
ATP or ADP substrates in the presence of Mg
2+ or Ca
2+.
Assays were performed at 37 -C as previously described
[12, 15, 23], modified from Fiske and Subbarow [34].
Nucleotidase activities were corrected for COS-1/pcDNA3
background (provided by the empty pcDNA3 vector trans-
fected into COS-1 cells) and for differences in expression
levels relative to those of wild-type, as determined by
Western blotting.
Western blot analysis
For Western blot, proteins were resolved in a 4%Y15%
linear gradient SDS-PAGE gradient gel (BioRad 4Y15%)
and transferred to a polyvinylidene fluoride (PVDF) mem-
brane. Blots were probed with an anti-C-terminal peptide
NTPDase3 antibody, as previously described [32].
Chemical cross-linking
COS cell membrane preparations (at a total protein
concentration of 0.1 mg/ml) were diluted in 20 mM
MOPS, 5 mM MgCl2 buffer, pH 7.4, and incubated for
20 min at 22 -C with 200 mM disuccinimido suberate
(DSS) freshly dissolved in DMSO. Non-cross-linked
samples were treated with the same volume of DMSO,
and the final DMSO concentration of all samples was less
than 2% of the total sample volume. The cross-linking
reaction was stopped by incubation with an excess (10
mM) of lysine for 5 min at 22 -C. Samples were then either
analyzed for intermolecular cross-linking by reducing
SDS-PAGE and Western blot analysis, or assayed for
Mg
2+-ATPase activity as described above.
Analysis of Cibacron blue binding
Cibacron blue binding assays have been described previ-
ously [12, 23, 29].
Native gel electrophoresis of wild-type and mutant
NTPDases
NTPDase3 membrane preparations were solubilized for
10 min at room temperature in digitonin (1% final con-
centration), a detergent known to preserve the native
quaternary structure and the activity of the NTPDases
[13, 14]. Soluble proteins were isolated by centrifugation
and run on 6% Laemmli native gel containing 0.1%
digitonin as described previously [12].
Treatment of wild-type and mutant NTPDase3
with Concanavalin A
Concanavalin A (Con A) was prepared at a concentration
of 5 mg/ml in 20 mM MOPS buffer containing 100 mM
NaCl, 1 mM MnCl2 and 1 mM CaCl2, pH 7.4. Wild-type
and tyrosine mutant NTPDase3 total membrane prepara-
tions (2 mg) were incubated with 5 ml of 5.0 mg/ml Con A
at 37 -C for 15 min before the addition of substrate.
Nucleotidase assays were performed in the presence of
5m MC a
2+ or Mg
2+, at a final nucleotide concentration of
2.5 mM.
N-acetylimidazole treatment
Membrane preparations were diluted to a total protein
concentration of 0.1 mg/ml in pH 7.4 MOPS buffer
containing 5 mM MgCl2. At 0 time (before addition of
N-acetylimidazole) 20-ml aliquots were diluted into
260 ml of an ice-cold stop solution containing an excess
of lysine (14.5 mM) to quench the reaction, 100 mM KCl,
5 mM MgCl2, 1 mM EGTA and 20 mM TrisYHCl, pH 7.0.
N-Acetylimidazole (2 mM) was then added to the remain-
der of each membrane preparation at 22 -C. At 5, 10, 20,
30, 45 and 60 min, 20 ml aliquots were diluted with
260 ml of stop solution as described above. At 61 min,
hydroxylamine was added to a final concentration of
200 mM to the remainder of the N-acetylimidazole-treated
membrane preparation to quench the reaction and reverse
the acetylation of tyrosine residues. At 62, 65, 75, 90 and
120 min, 21-ml aliquots were diluted with 259 ml stop
solution as before. Mg
2+-ATPase and Mg
2+-ADPase assays
were performed for all time points.
Time dependence of Mg-ATPase activity
Kinetics of Mg
2+-dependent ATPase hydrolysis before and
after treatment with N-acetylimidazole or the lysine-
specific cross linker, DSS, were measured in a Beckman
DU-800 spectrophotometer, using a NADH-linked-enzyme
spectrophotometric assay [35], as described previously for
NTPDase2 [22] and NTPDase3 [20]. The NADH-linked-
enzyme assay was used to allow the continuous monitoring
of ATPase activity as a function of time. After pre-
incubation to bring the cuvettes and samples to 37 -C, the
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NTPDase3 enzyme.
Solubilization and nucleotidase assays
Cell membranes (at a total protein concentration of 0.1 mg/
ml) were solubilized in 1% Triton X-100, 5 mM MgCl2
and 20 mM MOPS buffer pH 7.4 at 22 -C for 10 min with
occasional mixing, followed by centrifugation at 150,000 g
for 30 min at 22 -C. Mg
2+ and Ca
2+ ATPase and ADPase
activities were measured in presence of 0.1% Triton X-100,
after adding nucleotide to a final nucleotide concentration
of 0.435 mM, using a malachite green phosphate assay [36]
to measure nucleotidase activities, since Triton X-100
causes turbidity in the modified Fiske and Subbarow assay
[34].
Results
Rationale for selection and analysis of tyrosine mutants
We mutated several tyrosine residues (Tyr 252, 255, and
262) in the vicinity of a computer predicted, myc-type,
helixYloopYhelix dimerization domain (
238NTSDIMQVS
[31]), which is also nearby a region of the enzyme (ACR4a)
previously identified as containing a glycine residue
important for folding or structure of NTPDase3 (Gly 263
[12], see Table 1). Tyrosines corresponding to residues 252
and 255 in NTPDase3 are conserved in all NTPDases, while
the tyrosine analogous to tyrosine 262 in NTPDase3 is
conserved in the cell-surface membrane NTPDases
(NTPDase1, 2, and 3), but not in the other NTPDases (see
Table 1). Besides the sequence conservation and the location
of the tyrosine residues, another reason for analyzing these
mutations was suggested by the unusual experimental
observation that N-acetylimidazole, a tyrosine selective
chemical modification reagent, caused an increase in
enzymatic activity of wild-type NTPDase3 (Figures 1 and
2). We hypothesized that modification of one or more of
these tyrosine residues might be responsible for the
increased enzyme activity.
Protein expression levels
Expression levels of the NTPDase3 mutants were calcu-
lated by quantification of Western blots as previously
described [12] and compared to wild-type NTPDase3 using
an Alpha Innotech FluorChem 8800 Imager. The values
presented are the average of three separate transfections
(Table 2), and the specific activities for ATP and ADP of
the NTPDase3 mutants were corrected for variations in
expression levels relative to those of the wild-type (see
Table 2).
Nucleotidase activities of NTPDase3 mutants
ATPase and ADPase nucleotidase activities of all mutants
were determined in the presence of either Mg
2+ or Ca
2+
(Table 2). All tyrosine mutants were active and displayed
nucleotidase activities similar to the wild-type NTPDase3,
with expression levels 52%Y85% of the wild-type
NTPDase3 (Table 2). One difference noted is the increased
Mg
2+-ADPase activity of the Y255A (182%) and Y255F
(170%) mutants, relative to the wild-type.
N-acetylimidazole increases Mg
2+-ATPase/ADPase
activity
N-acetylimidazole increases both ATPase and ADPase
activity of wild-type NTPDase3 in presence of Mg
2+. After
60 min of reaction, Mg
2+-ATPase and Mg
2+-ADPase
activities are increased by approximately 1.9-fold (Figures
Table 1. Multiple sequence alignments of extended NTPDase ACR4a regions.
eNTPDase Species Accession no. Amino acid sequence
NTPDase3 Human AF034840 250 YVY Y YTLY Y YTHSFQCY Y YGRNEA
Rat NP_835207 250 YVY Y YTLY Y YTHSFQCY Y YGRNEA
Mouse AY376710 250 YVY Y YTLY Y YTHSFQCY Y YGRNEA
NTPDase2 Human Q9Y5L3 231 QHY Y YRVY Y YTHSFLCY Y YGRDQV
Rat O35795 231 QHY Y YRVY Y YTHSFLCY Y YGRDQI
Chicken P79784 228 QPY Y YKVY Y YTHSFLCY Y YGRDQV
NTPDase1 Human P49961 244 KDY Y YNVY Y YTHSFLCY Y YGKDQA
Mouse P55772 243 EDY Y YTVY Y YTHSFLCY Y YGKDQA
Pig Q9MYU4 244 KNY Y YSVY Y YTHSFLCY Y YGKDQA
NTPDase8 Mouse AY3644442 237 ANY Y YSVY Y YTHSYLCFGRDQI
NTPDase4 Human AF016032 309 HVY Y YRVY Y YVATFLGFGGNAA
NTPDase7 Human AF269255 309 HVY Y YRVY Y YVTTFLGFGGNFA
NTPDase5 Human AF039918 233 STY Y YKLY Y YTHSYLGFGKAAA
NTPDase6 Human AF039916 285 RTY Y YKLY Y YSYSYLGLGLMSA
The sequence alignment shows the region near apyrase conserved region 4a (ACR4a). The three tyrosine residues mutated in this work (human
NTPDase3 Y252, Y255, and Y262) are in bold and underlined in the aligned ACR4a sequences. The conserved glycine residue in ACR4a previously
shown to be important for the structure of NTPDase3 (G263, [12]) is italicized and double-underlined. Although only a few representative sequences of
the NTPDases are shown in the table, it should be noted that residues corresponding to tyr252 and tyr255 in NTPDase3 are conserved in all NTPDase
sequences determined to date.
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lower panels), respectively. A substantial portion of the
increase in activity is rapidly reversible by hydroxylamine
added at 61 min (Figures 1 and 2), suggesting that tyrosine
modification, rather than lysine modification, is responsi-
ble for the effect, since tyrosine modification, unlike lysine
modification by N-AI, is reversible by hydroxylamine. As
is evident from Figure 2, N-acetylimidazole is unable to
increase the nucleotidase activity of the Y252F mutant, in
contrast to the wild-type, Y255F, and Y262F mutant
NTPDase3. Interestingly, the N-acetylimidazole-induced
increase is also greatly attenuated in the Y255A mutant, as
well as being eliminated in the Y252A mutant (Figure 1).
Kinetics of Mg-ATPase activity after
N-acetylimidazole treatment
To investigate the reaction kinetics of Mg
2+-ATPase after
N-acetylimidazole-mediated chemical modification of
wild-type NTPDase3, continuous measurement of the
Mg-ATPase activity was made using the linked enzyme
assay. The data obtained was fit using a double exponential
decay function (Figure 3), suggesting two processes
causing decreases in enzymatic activity at 37 -C, which
occur on different time scales. N-Acetylimidazole decreases
the rate of decay of activity, resulting in the measured
increase in activity (Figures 1 and 2).
Table 2. Nucleotidase activities of wild-type (WT) and mutant NTPDase3 enzymes.
NTPDase3
enzyme
% Wt. level of
expression
Normalized
Mg
2+-ATPase
activity (% wt.)
Normalized
Ca
2+-ATPase
activity (% wt.)
Normalized
Mg
2+-ADPase
activity (% wt.)
Normalized
Ca
2+-ADPase
activity (% wt.)
Wild-type 100 144 T 10 (100) 413 T 35 (100) 57 T 5 (100) 83 T 15 (100)
Y252F 60 T 5 138 T 10 (95) 360 T 30 (87) 48 T 5 (84) 84 T 8 (101)
Y255F 85 T 7 170 T 12 (118) 397 T 24 (96) 97 T 12 (170) 96 T 10 (115)
Y262F 84 T 5 158 T 9 (109) 394 T 23 (95) 59 T 8 (103) 84 T 18 (101)
Y252A 52 T 6 140 T 12 (97) 345 T 36 (83) 51 T 7 (89) 86 T 7 (103)
Y255A 67 T 5 172 T 15 (119) 392 T 26 (95) 104 T 15 (182) 106 T 10 (127)
Y262A 70 T 4 159 T 7 (110) 410 T 25 (99) 60 T 12 (105) 85 T 20(102)
Values given represent the means T standard deviations of three separate transfections (which were matched to their own wild-type and empty pcDNA3
vector controls). Activities were measured in presence of 5 mM MgCl2 or CaCl2 at a final concentration of 2.5 mM ATP or ADP. Values were
normalized for different NTPDase3 protein expression levels by dividing the nucleotidase activity (expressed in the table as mmol Pi/mg protein/h) by
the expression level relative to the wild-type enzyme.
Figure 2. N-acetylimidazole increases NTPDase3 Mg
2+-ATPase and
Mg
2+-ADPase activities of wild-type, Y255F and Y262F mutants, but
not the Y252F mutant. Mutants [Y252F ()), Y255F (Ì), and Y262F
(¸)] and wild-type NTPDase3 () COS cell membrane preparations were
incubated with N-acetylimidazole for various times, and the reaction was
terminated by dilution into stop solution as described in Materials and
methods. Nucleotidase assays were performed in presence of 5 mM Mg
2+,
at a final nucleotide concentration of 2.5 mM. Top panel: ATPase
activities. Bottom panel: ADPase activities. Hydroxylamine was added to
a final concentration of 200 mM at 61 min, to reverse tyrosine
modification. All activities are expressed as a percentage of the
nucleotidase activities before N-acetylimidazole was added.
Figure 1. N-acetylimidazole increases NTPDase3 Mg
2+-ATPase and
Mg
2+-ADPase activities of wild-type and Y262A mutants, but not
Y252A or Y255A mutants. Mutants [Y252A ()), Y255A (Ì), and
Y262A (¸)] and wild-type NTPDase3 () COS cell membrane
preparations were incubated with N-acetylimidazole for various times,
and the reaction was terminated by dilution into stop solution as described
in Materials and methods. Nucleotidase assays were performed in the
presence of 5 mM Mg
2+, at a final nucleotide concentration of 2.5 mM.
Top panel: ATPase activities. Bottom panel: ADPase activities. Hydrox-
ylamine was added to a final concentration of 200 mM at 61 min, to
reverse tyrosine modification. All activities are expressed as a percentage
of the nucleotidase activities before N-acetylimidazole was added.
Identification of NTPDase3 residue modified by N-acetylimidazole 275Is N-acetylimidazole modification associated
with higher oligomer formation?
To investigate whether the N-acetylimidazole modification
triggers higher oligomer formation, wild-type NTPDase3
was treated with N-acetylimidazole for various times (0, 5,
30, 45 and 60 min) and then run on a native gel. All
samples ran with same electrophoretic mobility as untreat-
ed NTPDase3, indicating that N-acetylimidazole does not
initiate higher order oligomer formation as measured by
this technique. In addition, the electrophoretic mobilities of
wild-type NTPDase3 and the tyrosine mutants are indis-
tinguishable in this native gel electrophoresis, suggesting
that the mutants have the same gross oligomeric structure
as wild-type NTPDase3. Also, a lysine-specific cross-
linking agent, disuccinimido suberate (DSS), was used to
assess gross changes in quaternary structure. After reduc-
ing SDS-PAGE and Western blotting, wild-type and all
NTPDase3 mutants made in this study were similarly
cross-linked into dimers, suggesting that the gross quater-
nary structures of the mutants are similar to those of the
wild-type (all data mentioned above is not shown due to
lack of demonstrable differences between the wild-type
and mutant enzymes).
Analysis of tertiary structure of the mutants
by Cibacron blue binding
To explore the possibility of global misfolding induced by
point mutations leading to the inability to bind the
nucleotide analogue triazine dye, Cibacron blue, Cibacron
blue binding assays were performed as previously de-
scribed [12]. Misfolded mutants are unable to bind
Cibacron blue affinity matrix, as is denatured NTPDase3
(exemplified by the boiled, wild-type enzyme [12]). All the
mutants described in this study bound to the Cibacron blue
matrix like the wild-type enzyme (data not shown),
suggesting that there are no gross changes in tertiary
conformations of the mutants affecting the ability to bind
the nucleotide analogue, Cibacron blue.
Effect of N-acetylimidazole on Triton X-100 solubilized
wild-type NTPDase Mg-ATPase activity
To investigate whether N-acetylimidazole can increase
Mg
2+-ATPase activity of wild-type NTPDase3 after disso-
ciation into monomers by Triton X-100, wild-type
NTPDase3 was solubilized with Triton X-100 either prior
to, or after, treatment with N-acetylimidazole. The results
given in Table 3 indicate that N-acetylimidazole cannot
increase the Mg
2+-ATPase activity of Triton X-100
solubilized (monomeric) NTPDase3, and that after N-AI
is used to increase the activity of the membrane-bound
wild-type NTPDase3, that increase in activity is abolished
by subsequent Triton X-100 solubilization. Therefore, it
appears that the increase in enzyme activity seen upon N-
acetylimidazole treatment may be dependent on native
quaternary structure, or upon the native tertiary structure,
Figure 3. Time dependence of NTPDase3 Mg
2+-ATPase activity with and
without N-acetylimidazole treatment. Wild-type COS cell membrane
preparations were treated with water or N-acetylimidazole for 60 min
and the reaction was terminated by dilution in stop solution as described in
Materials and methods. The Mg
2+-ATPase activity of 3 mg protein was
measured by the NADH-linked enzyme assay [35].
Table 3. Effect of Triton X-100 solubilization on N-acetylimidazole
stimulation of wild-type NTPDase3 Mg
2+-ATPase activity.
Treatment Mg
2+-ATPase activity
(mmol/mg/h)
% Control
activity
None (control) 103 T 4 (100%)
N-acetylimidazole 229 T 10 220%
N-acetylimidazole,
then Triton X-100
7.0 T 1.5 6.8%
Triton X-100 5.6 T 0.6 5.4%
Triton X-100,
then N-acetylimidazole
5.6 T 0.6 5.4%
Figure 4. Effect of Concanavalin A pre-treatment on Mg
2+-ATPase
activities of wild-type and tyrosine mutant NTPDase3. Wild-type and
mutant COS cell membranes were pre-incubated with Con A for 15 min at
37 -C prior to addition of ATP to start the reactions as described in
Materials and methods. Data shown are the means T standard deviations
for each NTPDase3 sample.
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disruption of the quaternary structure by Triton X-100.
Effect of Concanavalin A on NTPDase3 wild-type and
tyrosine mutants
Concanavalin A is a tetravalent protein that binds to
glycans and can stabilize the oligomeric structure of glyco-
proteins by induction of the formation of protein oligo-
meric lattices [16]. Concanavalin A was previously shown
to increase the nucleotidase activity of several membrane
bound, oligomeric NTPDases [18, 22, 37, 38]. The elimi-
nation of a single glycosylation site located near ACR1
(N81 in NTPDase3) was shown to greatly diminish the
ability of Con A to increase the nucleotidase activity of
NTPDase3 [20]. Thus, we used Con A as another probe to
determine if the N-AI effect may be related to a quaternary
structure effect. The data in Figure 4 are consistent with the
N-acetylimidazole data in Figures 1 and 2, i.e., the mutants
which do not respond to N-AI also respond less to the
stimulating effect of Con A, suggesting some subtle con-
formational changes in the Y252F, Y252A, and Y255A
mutants, which may subtly affect the quaternary structure.
Effect of DSS chemical cross-linking on the
nucleotidase activity of tyrosine mutant
and wild-type NTPDase3
The lysine specific chemical modification reagent, DSS,
was used to treat wild-type and mutant NTPDases to
observe the effects on Mg-ATPase activities. As can be
seen in the top panel of Figure 5, DSS treatment increased
the activity of the wild-type as well as the Y255F and
Y262F mutants, but decreased the activity of the Y252F
mutant, whose activity is also not stimulated by N-
acetylimidazole (see Figure 2). In addition, the correlation
between stimulation of activity by N-AI and by DSS cross-
linking also exists for the tyrosine to alanine mutants, since
both Y252A and Y255A, which are not stimulated by N-AI
(see Figure 1), are also not stimulated by DSS cross-linking
(bottom panel of Figure 5).
Discussion
In this study we used site-directed mutagenesis to
mutate several conserved tyrosines to investigate which
tyrosine residue(s) is(are) responsible for mediating the
increase in Mg
2+-ATPase activity caused by acetylation
with the chemical modification reagent, N-acetylimidazole
(Table 1). These tyrosine residues (see Table 1) are in the
vicinity of the glycine residue that was previously proposed
to be important for NTPDase3 higher-order structure (due
to results obtained upon mutation of glycine 263 in ACR4a
[12]), and are also located near the computer-predicted
helixYloopYhelix dimerization domain [31] of NTPDase3
(
238NTSDIMQVS
246). These amino acids were first
changed to alanine to compare results to our previous
studies where NTPDase3 residues were typically mutated
to alanine [12, 23, 24, 29, 32]. However, for the purpose of
introducing the least structural perturbations and yet
allowing us to delineate the residue(s) modified by N-
acetylimidazole, these tyrosine residues were also mutated
to phenylalanine. As can be seen in Table 2, mutation of
none of these three tyrosine residues to either alanine or
phenylalanine inactivated the enzyme, indicating that they
are not an essential part of the catalytic site.
Upon treatment with N-acetylimidazole, wild-type
NTPDase3 displays a time-dependent increase in Mg
2+-
ATPase and Mg
2+-ADPase activities (see Figures 1 and 2).
A substantial portion of the increase in activity is rapidly
reversible by hydroxylamine treatment, suggesting that
tyrosine modification, rather than lysine modification, is
responsible for the effect. The Y252F mutant does not
exhibit this N-acetylimidazole-induced increase in activity,
while the nearby Y255F and Y262F mutants behave like
the wild-type enzyme (Figure 2). This suggests that
modification (acetylation by N-acetylimidazole) of tyrosine
at position 252 mediates the effect. However, it is not clear
why the increase in activity is not completely reversible
with hydroxylamine treatment, if the effect is solely
mediated by a single tyrosine acetylation, as the mutagenesis
results suggest. Consistent with the phenylalanine mutants,
the Y252A mutant is unresponsive to N-AI treatment.
However, the Y255A mutant, unlike the Y255F mutant, is
also largely unresponsive to N-AI treatment (Figure 1). The
reason for this is not known, but we speculate that the
Y255A mutation, being less conservative in nature and
introducing a substantially smaller side chain at that position
than the Y255F mutation, could cause a perturbation in the
folding in that area of the protein, resulting in a microen-
vironment at Y252 that is either less conducive for the
reaction of Y252 with N-AI, or alternatively, less conducive
Figure 5. Effect of DSS chemical cross-linking on Mg
2+-ATPase
activities of wild-type and tyrosine mutant NTPDase3. Wild-type and
mutant COS cell membranes were cross-linked with 200 mM DSS for 10
min at 22 -C as described in Materials and methods, the reactions stopped
by quenching with excess lysine, and the nucleotidase activities measured.
White bars are without DSS cross-linking (controls), while gray bars are
NTPDase3 samples after DSS cross-linking. Data shown are the means T
standard deviations for each NTPDase3 sample.
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after acetylation of Y252 by N-AI.
There are no obvious, global changes in tertiary or
quaternary structures in any of the mutants described in
this study, since all the mutants have expression levels
and enzyme activities not very different from the wild-
type enzyme (Table 2). In addition, they all behave like
wild-type NTPDase3 in Cibacron blue binding assays, as
well as on native gels, and have similar relative sus-
ceptibility to intermolecular DSS cross-linking (data not
shown since all characteristics were not different from the
wild-type).
However, we found that Triton X-100 solubilization
abolished the N-acetylimidazole-mediated increase in
Mg
2+-ATPase activity of wild-type NTPDase3, and that
monomerization by Triton X-100 solubilization subsequent
to stimulation of activity by N-AI negates the N-AI-
induced increase in activity (Table 3). This is important
since solubilization with Triton X-100 detergent has been
shown to cause a decrease in enzyme activity accompa-
nying disruption of the native oligomeric structure to
monomeric enzyme for both NTPDase1 (CD39 [14]) and
NTPDase3 [15]. This suggests that the N-acetylimidazole-
mediated increase in enzyme activity might be associated
with a subtle effect on the quaternary structure, which is
not detected by the global nature of the DSS cross-linking
and native gel analyses. Consistent with this is the fact that
the N-acetylimidazole induced increase of the ATPase
activity is more pronounced than the increase of the
ADPase activity (see Figures 1 and 2), since, based on
Triton X-100 solubilization (monomerization) experiments,
it appears that ATPase activity is more dependent on native
quaternary structure than ADPase activity for both
NTPDase1 [14] and NTPDase3 [15]. Also consistent with
the possibility that the N-acetylimidazole-mediated in-
crease in enzyme activity might be associated with a subtle
effect on the quaternary structure is the observation that
N-AI does not increase the activity (data not shown) of
bacterially expressed NTPDase6 [39], which is a soluble,
monomeric NTPDase that contains the conserved tyrosines
corresponding to residues 252 and 255 in NTPDase3 (see
Table 1). In addition, there is precedence for N-acetylimi-
dazole acetylation of proteins affecting quaternary struc-
ture and stability of oligomeric proteins, since Pal et al.
reported that this reagent acetylated surface exposed
tyrosine residues, resulting in a destabilization of the native
subunit assembly of the alpha-crystallin protein [40].
Alternatively, monomerization by Triton X-100 may also
modify the native tertiary structure of NTPDase3, and it
could be that this alteration in the tertiary structure leads to
the observed abolition of the N-acetylimidazole-mediated
increase in Mg-ATPase activity.
Concanavalin A, a tetravalent ligand known to stabilize
the oligomeric structure of glycoproteins by induction of
high-order protein oligomer lattice formation [16],
increases the nucleotidase activity of several eNTPDases
[18, 19, 37, 38, 41Y43]. This Con A effect has been
previously attributed to stabilization of the native quater-
nary structure [13, 20]. Thus, we used this lectin as an
additional probe of subtle conformational effects of the
mutations in this study. The results obtained (see Figure 4)
are consistent with, and complementary to, the N-AI results
in Figures 1 and 2. Thus, mutations in this region that
affect the ability of N-AI acetylation to increase NTPDase3
enzyme activity, possibly via subtle stabilization of the
native quaternary structure, also manifest themselves with
regard to the ability of Con A to stimulate enzyme activity.
As a result, Con A has a lesser effect on the activity of the
Y252F mutant than on the Y255F, Y262F, and wild-type
NTPDase3 (Figure 4, top panel).
Chemical cross-linking using the lysine-specific agent,
DSS, is also consistent with the N-AI and Con A results,
since the tyrosine mutants that are unable to respond to N-
AI also do not respond like the wild-type NTPDase3 to
DSS cross-linking with a similar increase in activity
(Figure 5). Instead of the increase in activity of the wild-
type enzyme, these mutants display reduced activities after
lysine-specific cross-linking (DSS treatment). This reduc-
tion in activity could be due to reaction at other lysine
residues, the negative effect of which is masked in the
wild-type enzyme by the larger positive effect on activity
after reaction with a different set of lysine residues.
Very recently, Grinthal and Guidotti [44] found that for
the related CD39/NTPDase1 protein, the CD39 dimer
appears to be in relatively rapid equilibrium with mono-
meric CD39. Thus, those authors proposed that NTPDase1
exists in a relatively unstable dimeric quaternary structure,
which allows exchange of monomer protein partners
between different dimers. Since the dimer form of
oligomeric NTPDases has higher nucleotidase activity
than the monomer form, it follows that any mutation or
chemical modification that shifts this monomerYdimer
equilibrium more towards the dimer would be expected
to increase enzyme activity. Thus, one possible explana-
tion for the N-acetylimidazole induced increase in
NTPDase3 activity observed in our studies is that
acetylation of tyrosine 252 causes a relatively small
increase in the stability of the dimer (i.e., slightly shifts
the monomerYdimer equilibrium more in favor of the
dimer), which is observed as an increase in activity, but is
not detected by the relatively crude chemical cross-linking
and native gel analyses utilized in this study.
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